Europe Nonalcoholic Fatty Liver Disease Market Report 2016

Publisher Name :
Date: 20-Sep-2016
No. of pages: 126
Inquire Before Buying

Notes:

Sales, means the sales volume of Nonalcoholic Fatty Liver Disease

Revenue, means the sales value of Nonalcoholic Fatty Liver Disease

This report studies sales (consumption) of Nonalcoholic Fatty Liver Disease in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

- Conatus Pharmaceuticals

- Daewoong Pharmaceutical

- Galmed International

- Kyorin Pharmaceutical

- Metabolic Solutions Development

- Novartis AG

- Phenex Pharmaceuticals

- Raptor Pharmaceuticals

- TCM Biotech International

- Tobira Therapeutics

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Nonalcoholic Fatty Liver Disease in these countries, from 2011 to 2021 (forecast), like

- Germany

- France

- UK

- Russia

- Italy

- Spain

- Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by Application, this report focuses on sales, market share and growth rate of Nonalcoholic Fatty Liver Disease in each application, can be divided into

- Application 1

- Application 2

- Application 3

Europe Nonalcoholic Fatty Liver Disease Market Report 2016

Table of Contents
Europe Nonalcoholic Fatty Liver Disease Market Report 2016
1 Nonalcoholic Fatty Liver Disease Overview
1.1 Product Overview and Scope of Nonalcoholic Fatty Liver Disease
1.2 Classification of Nonalcoholic Fatty Liver Disease
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Nonalcoholic Fatty Liver Disease
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Nonalcoholic Fatty Liver Disease Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Nonalcoholic Fatty Liver Disease (2011-2021)
1.5.1 Europe Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2021)
1.5.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
2 Europe Nonalcoholic Fatty Liver Disease by Manufacturers, Type and Application
2.1 Europe Nonalcoholic Fatty Liver Disease Market Competition by Manufacturers
2.1.1 Europe Nonalcoholic Fatty Liver Disease Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Nonalcoholic Fatty Liver Disease (Volume and Value) by Type
2.2.1 Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Type (2011-2016)
2.2.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Market Share by Type (2011-2016)
2.3 Europe Nonalcoholic Fatty Liver Disease (Volume and Value) by Countries
2.3.1 Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Nonalcoholic Fatty Liver Disease Revenue and Market Share by Countries (2011-2016)
2.4 Europe Nonalcoholic Fatty Liver Disease (Volume) by Application
3 Germany Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price)
3.1 Germany Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)
3.1.1 Germany Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
3.1.2 Germany Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
3.1.3 Germany Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
3.2 Germany Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
3.3 Germany Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
3.4 Germany Nonalcoholic Fatty Liver Disease Sales and Market Share by Application
4 France Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price)
4.1 France Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)
4.1.1 France Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
4.1.2 France Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
4.1.4 France Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
4.2 France Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
4.3 France Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
4.4 France Nonalcoholic Fatty Liver Disease Sales and Market Share by Application
5 UK Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price)
5.1 UK Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)
5.1.1 UK Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
5.1.2 UK Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
5.1.5 UK Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
5.2 UK Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
5.3 UK Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
5.4 UK Nonalcoholic Fatty Liver Disease Sales and Market Share by Application
6 Russia Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price)
6.1 Russia Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)
6.1.1 Russia Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
6.1.2 Russia Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
6.1.6 Russia Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
6.2 Russia Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
6.3 Russia Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
6.4 Russia Nonalcoholic Fatty Liver Disease Sales and Market Share by Application
7 Italy Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price)
7.1 Italy Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)
7.1.1 Italy Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
7.1.2 Italy Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
7.1.7 Italy Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
7.2 Italy Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
7.3 Italy Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
7.4 Italy Nonalcoholic Fatty Liver Disease Sales and Market Share by Application
8 Spain Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price)
8.1 Spain Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)
8.1.1 Spain Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
8.1.2 Spain Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
8.1.8 Spain Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
8.2 Spain Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
8.3 Spain Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
8.4 Spain Nonalcoholic Fatty Liver Disease Sales and Market Share by Application
9 Benelux Nonalcoholic Fatty Liver Disease (Volume, Value and Sales Price)
9.1 Benelux Nonalcoholic Fatty Liver Disease Sales and Value (2011-2016)
9.1.1 Benelux Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
9.1.2 Benelux Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
9.2 Benelux Nonalcoholic Fatty Liver Disease Sales and Market Share by Manufacturers
9.3 Benelux Nonalcoholic Fatty Liver Disease Sales and Market Share by Type
9.4 Benelux Nonalcoholic Fatty Liver Disease Sales and Market Share by Application
10 Europe Nonalcoholic Fatty Liver Disease Manufacturers Analysis
10.1 Conatus Pharmaceuticals
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Daewoong Pharmaceutical
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Galmed International
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Galmed International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Kyorin Pharmaceutical
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Metabolic Solutions Development
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Novartis AG
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Novartis AG Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Phenex Pharmaceuticals
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Raptor Pharmaceuticals
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 TCM Biotech International
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 TCM Biotech International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Tobira Therapeutics
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Tobira Therapeutics Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
11 Nonalcoholic Fatty Liver Disease Manufacturing Cost Analysis
11.1 Nonalcoholic Fatty Liver Disease Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Nonalcoholic Fatty Liver Disease Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Nonalcoholic Fatty Liver Disease Market Forecast (2016-2021)
14.1 Germany Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)
14.2 France Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)
14.3 UK Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)
14.4 Russia Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)
14.5 Italy Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)
14.6 Spain Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)
14.7 Benelux Nonalcoholic Fatty Liver Disease Sales Forecast (2016-2021)
14.8 Europe Nonalcoholic Fatty Liver Disease Sales Forecast by Type (2016-2021)
14.9 Europe Nonalcoholic Fatty Liver Disease Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Nonalcoholic Fatty Liver Disease
Table Classification of Nonalcoholic Fatty Liver Disease
Figure Europe Sales Market Share of Nonalcoholic Fatty Liver Disease by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Nonalcoholic Fatty Liver Disease
Figure Europe Sales Market Share of Nonalcoholic Fatty Liver Disease by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
Figure France Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
Figure UK Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
Figure Russia Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
Figure Italy Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
Figure Spain Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
Figure Benelux Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
Figure Europe Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2021)
Figure Europe Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
Table Europe Nonalcoholic Fatty Liver Disease Sales of Key Manufacturers (2015 and 2016)
Table Europe Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers
Figure 2016 Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers
Table Europe Nonalcoholic Fatty Liver Disease Revenue by Manufacturers (2015 and 2016)
Table Europe Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers
Table 2016 Europe Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers
Table Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Type (2011-2016)
Table Europe Nonalcoholic Fatty Liver Disease Sales Share by Type (2011-2016)
Figure Sales Market Share of Nonalcoholic Fatty Liver Disease by Type (2011-2016)
Figure Europe Nonalcoholic Fatty Liver Disease Sales Growth Rate by Type (2011-2016)
Table Europe Nonalcoholic Fatty Liver Disease Revenue and Market Share by Type (2011-2016)
Table Europe Nonalcoholic Fatty Liver Disease Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Nonalcoholic Fatty Liver Disease by Type (2011-2016)
Figure Europe Nonalcoholic Fatty Liver Disease Revenue Growth Rate by Type (2011-2016)
Table Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Countries (2011-2016)
Table Europe Nonalcoholic Fatty Liver Disease Sales Share by Countries (2011-2016)
Figure Sales Market Share of Nonalcoholic Fatty Liver Disease by Countries (2011-2016)
Table Europe Nonalcoholic Fatty Liver Disease Revenue and Market Share by Countries (2011-2016)
Table Europe Nonalcoholic Fatty Liver Disease Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Nonalcoholic Fatty Liver Disease by Countries (2011-2016)
Table Europe Nonalcoholic Fatty Liver Disease Sales and Market Share by Application (2011-2016)
Table Europe Nonalcoholic Fatty Liver Disease Sales Share by Application (2011-2016)
Figure Sales Market Share of Nonalcoholic Fatty Liver Disease by Application (2011-2016)
Figure Germany Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
Figure Germany Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
Figure Germany Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
Table Germany Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table Germany Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table Germany Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table Germany Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table Germany Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table Germany Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Figure France Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
Figure France Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
Figure France Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
Table France Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table France Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table France Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table France Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table France Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table France Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Figure UK Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
Figure UK Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
Figure UK Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
Table UK Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table UK Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table UK Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table UK Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table UK Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table UK Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Figure Russia Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
Figure Russia Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
Figure Russia Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
Table Russia Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table Russia Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table Russia Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table Russia Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table Russia Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table Russia Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Figure Italy Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
Figure Italy Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
Figure Italy Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
Table Italy Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table Italy Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table Italy Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table Italy Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table Italy Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table Italy Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Figure Spain Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
Figure Spain Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
Figure Spain Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
Table Spain Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table Spain Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table Spain Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table Spain Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table Spain Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table Spain Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Figure Benelux Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2016)
Figure Benelux Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2016)
Figure Benelux Nonalcoholic Fatty Liver Disease Sales Price Trend (2011-2016)
Table Benelux Nonalcoholic Fatty Liver Disease Sales by Manufacturers (2015 and 2016)
Table Benelux Nonalcoholic Fatty Liver Disease Market Share by Manufacturers (2015 and 2016)
Table Benelux Nonalcoholic Fatty Liver Disease Sales by Type (2015 and 2016)
Table Benelux Nonalcoholic Fatty Liver Disease Market Share by Type (2015 and 2016)
Table Benelux Nonalcoholic Fatty Liver Disease Sales by Application (2015 and 2016)
Table Benelux Nonalcoholic Fatty Liver Disease Market Share by Application (2015 and 2016)
Table Nonalcoholic Fatty Liver Disease Basic Information List
Table Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Daewoong Pharmaceutical Basic Information List
Table Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Galmed International Basic Information List
Table Galmed International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Galmed International Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Kyorin Pharmaceutical Basic Information List
Table Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Metabolic Solutions Development Basic Information List
Table Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Novartis AG Basic Information List
Table Novartis AG Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis AG Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Phenex Pharmaceuticals Basic Information List
Table Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Raptor Pharmaceuticals Basic Information List
Table Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table TCM Biotech International Basic Information List
Table TCM Biotech International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table TCM Biotech International Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Tobira Therapeutics Basic Information List
Table Tobira Therapeutics Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tobira Therapeutics Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nonalcoholic Fatty Liver Disease
Figure Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease
Figure Nonalcoholic Fatty Liver Disease Industrial Chain Analysis
Table Raw Materials Sources of Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
Table Major Buyers of Nonalcoholic Fatty Liver Disease
Table Distributors/Traders List
Figure Germany Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)
Figure Germany Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)
Figure France Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)
Figure France Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)
Figure UK Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)
Figure UK Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)
Figure Russia Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)
Figure Italy Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)
Figure Spain Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Nonalcoholic Fatty Liver Disease Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)
Table Europe Nonalcoholic Fatty Liver Disease Sales Forecast by Type (2016-2021)
Table Europe Nonalcoholic Fatty Liver Disease Sales Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Global Dental Bone Graft Substitutes Market Professional Survey Report 2017
    Published: 27-Apr-2017        Price: US 3500 Onwards        Pages: 111
    This report studies Dental Bone Graft Substitutes in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Geistlich - Zimmer - DePuy Synthes - Biomet - S......
  • Asia-Pacific Interferon Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 108
    In this report, the Asia-Pacific Interferon market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Interferon for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan......
  • Asia-Pacific Hyaluronic Acid Solution Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 117
    In this report, the Asia-Pacific Hyaluronic Acid Solution market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Doses), revenue (Million USD), market share and growth rate of Hyaluronic Acid Solution for these regions, from 2012 to 2022 (forecast), including - China - Japan - Sou......
  • Asia-Pacific Gastrointestinal Surgery Tissue Adhesive Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 114
    In this report, the Asia-Pacific Gastrointestinal Surgery Tissue Adhesive market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of Gastrointestinal Surgery Tissue Adhesive for these regions, from 2012 to 2022 (forecast), including - Chi......
  • Asia-Pacific Citrus Bioflavonoids Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the Asia-Pacific Citrus Bioflavonoids market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Citrus Bioflavonoids for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea......
  • Asia-Pacific Bioresorbable Implants Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 106
    In this report, the Asia-Pacific Bioresorbable Implants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Bioresorbable Implants for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Kor......
  • Asia-Pacific Anti-Infectives Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the Asia-Pacific Anti-Infectives market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Anti-Infectives for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Ta......
  • Asia-Pacific Albendazole Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 115
    In this report, the Asia-Pacific Albendazole market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Albendazole for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan......
  • EMEA (Europe, Middle East and Africa) Vascular Endothelial Growth Factor Inhibitor Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 115
    In this report, the EMEA Vascular Endothelial Growth Factor Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Vascular Endothelial Growth Factor Inhibitor for these regions, from 2012 to 2022 (forecast) - Europe:......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs